MoneyWorks4Me

MPS Pharmaa informs about statement of investor complaints

11 Oct 2024 Evaluate
As per the requirements of Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, MPS Pharmaa has informed that it enclosed Statement of Investor Complaints for the quarter ended 30th September, 2024.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..